Results 91 to 100 of about 23,497 (215)
Health Science Reports, Volume 9, Issue 4, April 2026.ABSTRACT Background and Aims Since the discovery of human immunodeficiency virus (HIV) mother to child transmission (MTCT), its prevention has been a priority. Guideline adherence has drastically reduced MTCT, virtually inexistent today in high‐income countries.
Boris Dmitrenko +5 more
wiley +1 more source
Retrovirology, 2019 Background Current efforts towards HIV-1 eradication focus on the reactivation and elimination of the latent viral reservoir, so-called shock and kill therapy.
Benjamin Trinité +2 more
doaj +1 more source
Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals. [PDF]
, 2015 BackgroundClinically significant dysregulation of the insulin-like growth factor (IGF) family proteins occurs in HIV-infected individuals, but the details including whether the deficiencies in IGFs contribute to CNS dysfunction are unknown.MethodsWe ...
Choi, Namjong +4 more
core +2 more sources
Frailty Transition Among Older Adults Living With HIV in Thailand: A 5‐Year Longitudinal Study
Journal of the International AIDS Society, Volume 29, Issue 4, April 2026.ABSTRACT Introduction Frailty is highly prevalent among older people with HIV (PWH), driven by multimorbidity and HIV‐associated accelerated ageing. We investigated frailty transitions and associated factors over a 5‐year follow‐up period in an ageing cohort of PWH in Thailand. Methods We conducted a prospective cohort study among PWH aged ≥50 years in
Tanakorn Apornpong +9 more
wiley +1 more source
HIV-1 infection among women in Israel, 2010–2018
BMC Infectious Diseases, 2020 Introduction Although women comprise 33% of the HIV-1-carriers in Israel, they have not previously been considered a risk group requiring special attention.
Tali Wagner +9 more
doaj +1 more source
HIV‐1 Non Group‐M Phenotypic Susceptibility to Ibalizumab
Journal of Medical Virology, Volume 98, Issue 4, April 2026.ABSTRACT The study assessed the phenotypic susceptibility of non group‐M human immunodeficiency virus type 1 (HIV‐1/non‐M) clinical isolates to ibalizumab, the first‐in‐class long‐acting CD4‐directed post‐attachment inhibitor. Thirty isolates were tested: 1 HIV‐1/M (reference strain BRU.HXB2), 2 HIV‐1/N, 26 HIV‐1/O and 1 HIV‐1/P.
Lucie Poisson +6 more
wiley +1 more source
Indian Dermatology Online Journal, 2014 Nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI) is one of the important components of highly active antiretroviral therapy. It is sometimes associated with life-threatening adverse reactions.
Leelavathy Budamakuntla +4 more
doaj +1 more source
Characteristics, Immunological Response & Treatment Outcomes of HIV-2 Compared with HIV-1 & Dual Infections (HIV 1/2) in Mumbai [PDF]
, 2010 Information available on HIV-2 and dual infection (HIV-1/2) is limited. This study was carried out among HIV positive individuals in an urban referral clinic in Khar, Mumbai, India, to report on relative proportions of HIV-1, HIV-2 and HIV-1/2 and ...
Alaka, Deshpande +8 more
core +1 more source
Virological outcomes of second-line protease inhibitor-based treatment for human immunodeficiency virus type 1 in a high-prevalence rural South African setting: a competing-risks prospective cohort analysis [PDF]
, 2017 Background. Second-line antiretroviral therapy (ART) based on ritonavir-boosted protease inhibitors (bPIs) represents the only available option after first-line failure for the majority of individuals living with human immunodeficiency virus (HIV ...
2LADY Study Group +22 more
core +3 more sources
Open Forum Infectious Diseases, 2019 Abstract Background Doravirine, rilpivirine, and etravirine are newer generation non-nucleoside reverse transcriptase inhibitors (NNRTI) that are intended to be more durable alternatives to efavirenz and nevirapine.
Theresa Dungca, Nina +16 more
openaire +1 more source